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Abstract: Infection with the hepatitis E virus (HEV) is one of the most common causes, if not the
most common, of acute hepatitis worldwide. In the last decade, we have learned that in addition to
the endemically and epidemically occurring form of hepatitis E, which is predominantly transmitted by
contaminated drinking water, and constitutes a significant health problem in resource-poor countries,
there is a globally existing form of hepatitis E, which is a zoonosis, and as such primarily transmitted
by the consumption of contaminated meat products. Although in most cases hepatitis E is subclinical
or mild and self-limiting, pregnant women and patients with liver cirrhosis may have severe, occasionally
even fatal disease, and immunocompromised individuals may develop chronic hepatitis E. Considering
the substantial global health burden caused by HEV infection, it is surprising how limited our knowledge
of hepatitis E pathology still is. In this paper, we describe localization studies on HEV infection and
discuss their implications for everyday diagnostics. Furthermore, we outline and discuss the spectrum of
histologic changes, which can be found in HEV infection in various clinical contexts.
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Abstract 
Infection with the hepatitis E virus (HEV) is one of the most common causes, if not the most 
common, of acute hepatitis worldwide. In the last decade, we have learned that in addition to 
the endemically and epidemically occurring form of hepatitis E, which is predominantly 
transmitted by contaminated drinking water, and constitutes a significant health problem in 
resource-poor countries, there is a globally existing form of hepatitis E, which is a zoonosis, 
and as such primarily transmitted by the consumption of contaminated meat products. 
Although in most cases hepatitis E is subclinical or mild and self-limiting, pregnant women 
and patients with liver cirrhosis may have severe, occasionally even fatal disease, and 
immunocompromised individuals may develop chronic hepatitis E. Considering the 
substantial global health burden caused by HEV infection, it is surprising how limited our 
knowledge of hepatitis E pathology still is. In this paper, we describe localization studies on 
HEV infection and discuss their implications for everyday diagnostics. Furthermore, we 
outline and discuss the spectrum of histologic changes, which can be found in HEV infection 
















Hepatitis E, caused by an infection with the hepatitis E virus (HEV), which belongs to the 
family Hepeviridae, is one of the most frequent, perhaps even the most frequent causes of 
acute hepatitis worldwide, and thus represents a major global health problem.(1, 2) The 
question of how pathologists come into contact with hepatitis E essentially depends on which 
part of the world they are practicing in.(1, 3) 
HEV infection is widespread worldwide, but it manifests differently depending on the 
geographical region. Well documented has been a major epidemic that broke out in Delhi, 
India, in the mid-1950s which is now considered to be the first description of hepatitis E,(4) 
as well as another epidemic in Kashmir in the late 1970s.(5) In the early 1980s, a new virus 
was identified and cloned in connection with a major outbreak of unexplained hepatitis A 
virus (HAV)- and hepatitis B virus (HBV)-negative hepatitis in Afghanistan, which was 
subsequently referred to as hepatitis E virus (HEV).(6, 7) Later on, the above mentioned 
Delhi and Kashmir epidemics, respectively, could also retrospectively be classified as 
Hepatitis E. In countries in Asia, Africa and Central America, hepatitis E often occurs in this 
epidemic form. It is caused by genotypes (gt) 1 and 2, and mainly transmitted by 
contaminated drinking water. The clinical manifestation of HEV infection is very variable.(1) 
In most cases, the infection is asymptomatic, but can also be severe and even lethal.(8, 9) 
Pregnant women and patients with a pre-existing severe liver disease are particularly at risk 
of worse outcome.(5, 10) 
A few years ago, our perception of hepatitis E started to change, after it had become obvious 
that, in addition to the epidemic form described above, there is another manifestation of 
hepatitis E which represents a zoonosis occurring globally including in particular also Europe 
and North America.(11-14) This autochthonous form of hepatitis E is caused by the 












reservoir for these viruses are pigs and wild boars.(1) The virus is transmitted mainly through 
the consumption of meat products that are not cooked sufficiently. What was surprising at 
that time was the realization that authochthonous HEV infection can also lead to chronic 
progressions in immunocompromised individuals,(15-18) which in this form had not been 
described before in the epidemic form. 
 
At the molecular and cell biological level, we now have a solid understanding of central 
processes of HEV infection, in particular of the function of the three major proteins encoded 
by three different open reading frames (ORF). While the ORF1 protein (pORF1) is 
responsible for virus replication, the ORF2 protein (pORF2) is the capsid, which also forms 
the main antigenic structure and is used for vaccination. The ORF3 (pORF3) protein in turn is 
responsible for the release of viral particles from the cell.(2, 19)  
Considering the frequency of hepatitis E worldwide and the large global health burden it 
represents, it is amazing how rudimentary the picture was until recently that we had of the 
course of infection in vivo, especially in the tissue context of the human liver. Insights into the 
life cycle of the virus could be gained in recent years by analyzing chimeric mice with human 
liver cells.(20-22) Although these models are suitable to study the life cycle in the 3D tissue 
context, and also allow to perform drug testing, they are limited in that the natural cellular and 
humoral human immune response cannot be recapitulated.(23, 24) Our own group has 
recently performed systematic analyses on the localization of HEV RNA and the three major 
HEV proteins (pORF1, pORF2 and pORF3) not only in the cell culture system but also in 
liver tissue of hepatitis E patients. Following this approach, we were able to perform in situ 
RNA hybridization and immunohistochemistry on formalin-fixed, paraffin-embedded (FFPE) 
tissue, allowing us to simultaneously localize HEV RNA and proteins directly in human livers, 
and semi-quantitatively describe the subcellular localization of the three proteins.(25) We 
made interesting observations especially for the HEV pORF2 protein. On the one hand, we 












was surprising at the time, but has now been confirmed by other groups.(26) On the other 
hand, we were able to show that pORF2, unlike pORF1 and pORF3, can also be visualized 
very well in FFPE material of HEV-infected livers, so that the immunohistochemistry of 
pORF2 can also be used for diagnostic purposes. (FIGURE 1 A) This provides us a robust 
method for the histopathologic diagnosis of hepatitis E.(27, 28)   
 
Immunohistochemistry for the presentation of HEV infection is a valuable ancillary test in 
everyday diagnostics, since the histologic changes that can occur in hepatitis E are very 
variable, thus making the histopathologic differential diagnosis of hepatitis E really 
challenging.(29) Compared to other viral hepatitis, there are few reports on histologic 
changes.(30) The histology of the epidemic form of hepatitis E has already been described in 
detail in the context of the above mentioned historical hepatitis epidemic in India in a 
substantial case number cohort of 90 biopsies, whereby a cholestatic form was distinguished 
from a non-cholestatic form.(31) In reports on the acute autochthonous form of hepatitis E 
with significantly smaller case numbers, changes similar to those observed in hepatitis A 
were described.(32-34) In summary, key histologic features of the acute hepatitis pattern are: 
Expanded portal tracts with a mixed infiltrate including lymphocytes, plasma cells and 
granulocytes, lobular disarray, Kupffer cell activation, variable degree of (mostly spotty) 
hepatocyte necrosis, hepatocyte swelling and ballooning degeneration, cholestatic rosettes, 
canalicular and cytoplasmic bilirubinostasis, biliary epithelial damage, and cholangitis.(30, 
35) (FIGURE 1 B) 
In reports on persistent / chronic courses of HEV infection in immunosuppressed patients, 
histologic changes similar to those in other forms of chronic hepatitis were described, 
including the development of portal-emphasized chronic inflammation and fibrosis.(15, 36) 
Furthermore, cases with almost only reactive changes(36) or a prominent cholangitic 
component(37) have been described. In summary, key histologic features of the chronic 












interface activity possible, variable degree of hepatocyte necrosis (mostly single scattered 
apoptotic hepatocytes), and variable degree of fibrosis possible.(30) (FIGURE 1 C) 
The above mentioned compilation of reports on hepatitis E-associated histopathologic 
changes, supplemented by our own observations,(29, 35) shows how heterogeneous the 
histopathologic findings in hepatitis E are. Thus, it becomes clear that these changes overlap 
extensively with histologic changes observed in other diseases. For the acute, self-limiting 
form of hepatitis E, these are mainly: Hepatotropic viruses other than E, non-hepatotropic 
viruses, autoimmune hepatitis (AIH), drug-induced liver injury and toxins as well as metabolic 
diseases (e.g. Wilson's disease). For the chronic form of hepatitis E, these are mainly: 
Hepatotropic viruses other than E, non-hepatotropic viruses, autoimmune hepatitis (AIH), 
drug-induced liver injury,(38) and in the context of transplantation also T-cell mediated 
rejection in (liver) transplant patients, graft versus host disease (GvHD) in hematologic stem 
cell transplanted patients, and recurrence of viral hepatitis. 
In a special situation are patients with pre-existing (severe) liver disease in whom an 
additional hepatitis E infection is more difficult to detect clinically and histopathologically 
against the background of the pre-existing disease.(39-41) (FIGURE 1 D) It is therefore given 
that differential diagnosis is extremely challenging, which is made even more difficult by the 
fact that the clinical pictures also overlap. Therefore, the correlation with the clinical context, 
which is generally recommended in hepatopathology, is especially important for hepatitis E.  
 
In summary, immunohistochemistry for HEV pORF2 has become a robust and helpful tool for 
histopathologic diagnostics. The fact that hepatitis E associated histologic changes cover a 
very broad spectrum ranging from a nearly normal liver histology, over acute and chronic 
hepatitis patterns to (sub)-total liver necrosis, together with the notion that no pathognomonic 
or even characteristic changes could be defined so far (and probably do not exist), makes 












on the clinical context, it is advisable to consider this for the differential diagnosis of hepatitis 
E in everyday life. 
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Fig. 1. Histopathologic findings observed in liver biopsies from patients with HEV 
infection: (A) HEV-pORF2 immunohistochemistry with geographically distributed positive 
areas and different staining patterns: e.g. predominantly cytoplasmic (upper insert) or 
predominantly nuclear (lower insert). (B) Acute hepatitis pattern with severe lobular disarray, 
hepatocyte damage and cholestasis. (C) Chronic hepatitis pattern with portal-based 
mononuclear inflammation, some interface activity, single scattered apoptotic hepatocytes 
(arrow head) and development of fibrosis (insert Sirius red). (D) Acute on chronic liver 
damage pattern with signs f nutritive-toxic damage, inflammation and cirrhosis (insert Sirius 
red). Scale bars 250 m for H&E overviews in A-D and Sirius red in C-D; scale bar 25 m for 
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